Raycaster/ Eval

Company environment · Targeted small molecules · multi-market

A targeted cancer pill across markets

Jobs span early trials through approval and later expansions. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.

1What does this company do?

A drug company taking a targeted cancer pill through trials, approval, and new uses.

The company takes one medicine from early trials, through approval in the US and abroad, to a later approval for a new type of cancer — and each decision has to rest on what was knowable at that date, not on what became clear later.

For experts

Originator sponsor of a targeted oncology small molecule; records span IND expedited-program decisions through approval-day disposition and affiliate close-out.

2Where is the product on its way to patients?

The pill is approved, sold, and being extended to new uses and new countries.

  1. 1Discovery
  2. 2Lab & animal studies
  3. 3Human trials
  4. 4Filing & review
  5. 5Approved
  6. 6On the market
    • The product is here

Jobs sit at different dates — early development, the approval date, and a later filing for a new use — and every call must be made from that day’s record alone.

For experts

Targeted oncology small molecule; dated snapshots at an expedited-program decision, the US approval date, a European regulator’s close-out, and an amendment-cycle disposition.

3What is happening right now?

Several dated moments, each with its own decision.

Whether to ask for a faster review path early on, how to answer a foreign regulator, how to close out a round of study-plan amendments, and how to line up records on the approval date.

4Which jobs were the models given?

4 jobs, each graded against a specialist’s checklist.

Scores are checks passed out of checks in the list. Each model ran each job once.

JobSolOpusDeepSeekAstra
01Choose the expedited-program position — request Fast Track now, wait for an FDA meeting, or hold — and disposition the other options.10/1510/157/1513/15
02Turn today’s approval letter into one disposition the publishing and affiliate teams can execute — what moves now, what stays held.5/1514/156/1514/15
03Lock the registered-condition package for a European regulator’s open quality questions.5/128/12—9/12
04Close the open amendment-cycle actions and make the disposition file and trackers agree.3/84/8—7/8

This company’s files stay private.

The jobs on this page are scored as part of the official 71-task benchmark. The files, the model’s steps, and each check stay unpublished, because they come from a real product’s records. To follow a job all the way down, open one of our open companion showcases (evaluated separately from the benchmark totals).

Havenor Therapeutics (fictional showcase) →
Broad Institute (public FDA record showcase) →

← Back to all company environments